Status:
UNKNOWN
Sleep Support for Children With Neurodevelopmental Disorders
Lead Sponsor:
Sheffield Children's NHS Foundation Trust
Conditions:
Sleep Hygiene
Sleep Wake Disorders
Eligibility:
All Genders
4-11 years
Phase:
NA
Brief Summary
Around 80% of children with neurodevelopmental disorders such as Attention Deficit Hyperactivity Disorder (ADHD) and autism are reported to have significant difficulties with sleep. This may be a prob...
Detailed Description
Sleep is a restorative process, fundamental to physical and psychological health. Sleep disturbances including bedtime resistance and night-time awakening occur in 80% children with neurodisability, t...
Eligibility Criteria
Inclusion
- Children to be included will fulfil all of the inclusion criteria.
- Formal diagnosis of ADHD, autism or another neurodevelopmental condition,
- Age 4-11 years,
- Severe sleep disturbance (defined as Score of 3 or more on Composite Sleep Disturbance Index),
- Been taking melatonin to aid sleep onset for more than 12 months
Exclusion
- Exclusion Criteria
- Already accessed a sleep clinic at Sheffield Children's Hospital or The Sleep Charity.
- English not first language
Key Trial Info
Start Date :
January 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT05971212
Start Date
January 29 2021
End Date
September 30 2023
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Facility, Sheffield Children's Hospital
Sheffield, United Kingdom